We are presenting our data at the DDR inhibitor summit, January 24 – 26, 2023, Boston, US
We are excited to hear about the newest progress in the DDR field and look forward to all interesting
discussions.
Detailed mode of action of the MTHFD1/2 inhibitor TH9619 now published in Nature Metabolism
The One-carbon Therapeutics team is proud and excited to share
